Skip to content

US · OMDA · MEDICAL - HEALTHCARE INFORMATION SERVICES

Omada Health (OMDA) intrinsic value and stock valuation

$11.87as of 2026-11-21 · Mkt cap 1.41B

Data updated · price as of 2026-11-21

Strongly undervaluedIC value is more than 50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Omada Health DCF and intrinsic value

InvestorsCraft values OMDA with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from OMDA’s statements →

Omada Health Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Healthcare Information Services San Francisco, CA 94080 omadahealth.com

How the business is doing

Fiscal 2022–2025, USD

Revenue
$260.2M
20222025
Net income
-$-12.78M
20222025
Free cash flow
$16.9M
20222025
Total equity
$229.7M
20222025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2022–2025, USD
2025202420232022
Revenue$260.2M$169.8M$122.8M$89.2M
Operating income-$-11.97M-$-43.65M-$-66M-$-72.35M
Net income-$-12.78M-$-47.14M-$-67.51M-$-72.52M
EPSd-$-218.72K-$-845.71K-$-1.21M-$-1.3M
Operating cash flow$18.3M-$-34.18M-$-49.74M-$-68.98M
Capital expenditure-$-1.32M-$-3.86M-$-2.92M-$-2.72M
Free cash flow$16.9M-$-38.04M-$-52.66M-$-71.7M
Total assets$305.4M$150.9M$175.1M$221.8M
Total debt$0.00$30.2M$30.6M$30.8M
Net debt-$-222.04M-$-46.21M-$-85.06M-$-137.31M
Total equity$229.7M$64.6M$98.9M$155.6M
Cash and short-term investments$222M$76.4M$115.6M$168.1M
Income statement
2025202420232022
Revenue$260.2M$169.8M$122.8M$89.2M
Cost of revenue$89.3M$66.9M$52.8M$46.4M
Gross profit$170.9M$102.9M$70M$42.8M
Research and development expenses$40.7M$35.9M$33.7M$26.2M
Selling, general and administrative expenses$142.2M$110.6M$102.2M$89M
Other expenses$0.00$0.00$0.00$0.00
Operating expenses$182.9M$146.5M$136M$115.1M
Cost and expenses$272.2M$213.5M$188.8M$161.5M
Interest income$5.3M$810K$5.78M$2.2M
Interest expense$2.53M$4.51M$4.71M$4.2M
Depreciation and amortization$5.49M$4.8M$4.45M$4.33M
Ebitda-$-4.75M-$-37.83M-$-58.36M-$-63.99M
Operating income-$-11.97M-$-43.65M-$-66M-$-72.35M
Total other income/expenses, net-$-810K-$-3.48M-$-1.51M-$-170K
Income before tax-$-12.78M-$-47.14M-$-67.51M-$-72.52M
Income tax expense$0.00$0.00$0.00$0.00
Net income-$-12.78M-$-47.14M-$-67.51M-$-72.52M
Weighted average shares outstanding$58.4M$55.7M$55.7M$55.7M
Weighted average diluted shares outstanding$58.4M$55.7M$55.7M$55.7M
Balance sheet
2025202420232022
Cash and short-term investments$222M$76.4M$115.6M$168.1M
Net receivables$34.6M$23.9M$16.4M$11.7M
Inventory$4.49M$3.3M$3.61M$3.54M
Total current assets$272.9M$113.1M$142.9M$188.6M
Property, plant and equipment, net$7.94M$6.07M$5.6M$6.06M
Goodwill and intangible assets$15.7M$17.5M$19.5M$21.6M
Long-term investments$0.00$0.00$0.00$0.00
Total non-current assets$32.5M$37.8M$32.2M$33.2M
Total assets$305.4M$150.9M$175.1M$221.8M
Accounts payable$10.3M$4.17M$3.62M$4.11M
Short-term debt$0.00$410K$790K$650K
Deferred revenue$25.1M$19.5M$14.9M$13.4M
Total current liabilities$75.7M$54M$43.8M$34.5M
Long-term debt$0.00$29.8M$29.8M$30.2M
Deferred revenue, non-current$0.00$0.00$0.00$0.00
Total non-current liabilities$0.00$32.3M$32.4M$31.7M
Capital lease obligations$0.00$410K$1.2M$1.91M
Total liabilities$75.7M$86.3M$76.2M$66.2M
Common stock$60K$10K$10K$20K
Retained earnings-$-456.74M-$-443.97M-$-396.83M-$-329.32M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00
Total equity$229.7M$64.6M$98.9M$155.6M
Total investments$0.00$0.00$0.00$0.00
Total debt$0.00$30.2M$30.6M$30.8M
Net debt-$-222.04M-$-46.21M-$-85.06M-$-137.31M
Cash flow statement
2025202420232022
Net income-$-12.78M-$-47.14M-$-67.51M-$-72.52M
Depreciation and amortization$5.49M$4.8M$4.45M$4.33M
Stock-based compensation$13M$9.42M$8.74M$6.65M
Change in working capital$3.74M-$-6.57M-$-1.5M-$-9.14M
Accounts receivable-$-12.36M-$-8.8M-$-5.34M-$-3.93M
Inventory-$-1.19M$320K-$-70K-$-1.95M
Accounts payable$6.29M$400K-$-290K-$-4.99M
Net cash provided by operating activities$18.3M-$-34.18M-$-49.74M-$-68.98M
Investments in property, plant and equipment-$-1.32M-$-600K-$-420K-$-720K
Acquisitions, net$0.00$0.00$0.00$0.00
Net cash used for investing activities-$-5.83M-$-3.86M-$-2.92M-$-2.72M
Common stock issued$169.9M$3.33M$1.75M$1.74M
Common stock repurchased$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00
Net cash used for financing activities$133.2M-$-1.21M$180K$16.3M
Net change in cash$145.6M-$-39.25M-$-52.48M-$-55.38M
Cash at end of period$222M$76.4M$115.6M$168.1M
Operating cash flow$18.3M-$-34.18M-$-49.74M-$-68.98M
Capital expenditure-$-1.32M-$-3.86M-$-2.92M-$-2.72M
Free cash flow$16.9M-$-38.04M-$-52.66M-$-71.7M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Omada Health

        Omada Health is an American virtual health company that delivers evidence-based digital programs designed to manage common chronic ailments, including cardiometabolic, musculoskeletal, and behavioral health conditions, offering continuous support that bridges the gap between in-person medical appointments.

        CEO
        Sean Duffy
        Employees
        916
        Beta
        1.72

        Explore

        Frequently asked questions

        What is the intrinsic value of Omada Health (OMDA)?

        Omada Health (OMDA) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is OMDA undervalued?

        OMDA trades at a price of $11.87 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.